• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与 1 型糖尿病纵向研究中高保留率相关的参与者特征和研究特征。

Participant characteristics and study features associated with high retention rates in a longitudinal investigation of type 1 diabetes mellitus.

机构信息

Department of Psychiatry, University of Iowa Carver College of Medicine, Iowa City, 52242-1000, USA.

出版信息

Clin Trials. 2012 Dec;9(6):798-805. doi: 10.1177/1740774512458986. Epub 2012 Oct 1.

DOI:10.1177/1740774512458986
PMID:23027646
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3762976/
Abstract

BACKGROUND

The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study has sustained an extraordinarily high level of participant involvement for over two decades.

PURPOSE

In order to identify specific characteristics of EDIC that contributed most strongly to retention, study-designed questionnaires were distributed to 1334 participants.

METHODS

Confidential questionnaires were completed during EDIC Years 15-17. Participants were classified as Completely Adherent (completed all visits), Partly Adherent (missed >1 visit or major portion of a visit), or Inactive (did not participate for >5 years). Questionnaire items addressed specific aspects of clinic visits, evaluation procedures, staff-participant relationships, and medical/health-care support provided by EDIC.

RESULTS

The most commonly cited reasons for continuing participation were Cutting Edge Tests to assess diabetes complications (79.3%), Annual Evaluations (67.7%), a desire to Help Others (65.2%), and Better Care for Diabetes (61.6%). Women chose Cutting Edge Tests as their first or second most important reason significantly more often than men, whereas men chose Better Care for Diabetes more frequently. Individuals with at least three diabetes-related complications were more likely than those with fewer complications to choose Annual Evaluations as their first or second reason for continued involvement.

LIMITATIONS

The small proportion of individuals who discontinued participation restricted our ability to identify factors associated with suspended involvement. In addition, our analysis is limited to a cohort with type 1 diabetes followed in an observational study after an average participation time of 6.5 years in a randomized trial.

CONCLUSIONS

The primary reasons identified by respondents for their long-term commitment are consistent with shorter-term studies and underscore the importance of expert medical care, supportive staff-participant relationships, and involvement with clinically and scientifically meaningful research.

摘要

背景

糖尿病控制和并发症试验/糖尿病干预和并发症的流行病学(DCCT/EDIC)研究在超过二十年的时间里一直保持着极高的参与者参与度。

目的

为了确定对保留率贡献最大的 EDIC 的具体特征,研究设计了问卷并分发给 1334 名参与者。

方法

在 EDIC 第 15-17 年期间完成了机密问卷。参与者被分为完全依从者(完成了所有的就诊)、部分依从者(错过>1 次就诊或就诊的大部分时间)或不活跃者(>5 年未参与)。问卷项目涉及诊所就诊、评估程序、工作人员-参与者关系以及 EDIC 提供的医疗/保健支持的具体方面。

结果

继续参与的最常见原因是进行前沿测试以评估糖尿病并发症(79.3%)、年度评估(67.7%)、帮助他人的愿望(65.2%)和更好的糖尿病护理(61.6%)。女性选择前沿测试作为他们的第一或第二重要原因的频率明显高于男性,而男性更频繁地选择更好的糖尿病护理。至少有三种糖尿病相关并发症的个体比并发症较少的个体更有可能选择年度评估作为他们继续参与的第一或第二原因。

局限性

停止参与的人数比例较小,限制了我们识别与暂停参与相关因素的能力。此外,我们的分析仅限于在一项观察性研究中,在一项随机试验中平均参与时间为 6.5 年后,对 1 型糖尿病患者进行随访的队列。

结论

受访者长期承诺的主要原因与短期研究一致,并强调了专家医疗保健、支持性工作人员-参与者关系以及参与具有临床和科学意义的研究的重要性。

相似文献

1
Participant characteristics and study features associated with high retention rates in a longitudinal investigation of type 1 diabetes mellitus.与 1 型糖尿病纵向研究中高保留率相关的参与者特征和研究特征。
Clin Trials. 2012 Dec;9(6):798-805. doi: 10.1177/1740774512458986. Epub 2012 Oct 1.
2
Epidemiology of Diabetes Interventions and Complications (EDIC). Design, implementation, and preliminary results of a long-term follow-up of the Diabetes Control and Complications Trial cohort.糖尿病干预与并发症流行病学研究(EDIC)。糖尿病控制与并发症试验队列长期随访的设计、实施及初步结果。
Diabetes Care. 1999 Jan;22(1):99-111. doi: 10.2337/diacare.22.1.99.
3
Evolution of the study coordinator role: the 28-year experience in Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC).研究协调员角色的演变:在糖尿病控制和并发症试验/糖尿病干预和并发症的流行病学(DCCT/EDIC)中的 28 年经验。
Clin Trials. 2012 Aug;9(4):418-25. doi: 10.1177/1740774512449532. Epub 2012 Jun 22.
4
The diabetes control and complications trial/epidemiology of diabetes interventions and complications study at 30 years: summary and future directions.糖尿病控制与并发症试验/糖尿病干预与并发症的流行病学研究30年:总结与未来方向
Diabetes Care. 2014;37(1):44-9. doi: 10.2337/dc13-2148.
5
Effect of intensive glycemic control and diabetes complications on lower urinary tract symptoms in men with type 1 diabetes: Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) study.强化血糖控制及糖尿病并发症对1型糖尿病男性下尿路症状的影响:糖尿病控制与并发症试验/糖尿病干预与并发症流行病学(DCCT/EDIC)研究
Diabetes Care. 2009 Apr;32(4):664-70. doi: 10.2337/dc07-2375. Epub 2009 Jan 26.
6
Long-term renal outcomes of patients with type 1 diabetes mellitus and microalbuminuria: an analysis of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications cohort.1型糖尿病合并微量白蛋白尿患者的长期肾脏转归:糖尿病控制与并发症试验/糖尿病干预与并发症流行病学队列分析
Arch Intern Med. 2011 Mar 14;171(5):412-20. doi: 10.1001/archinternmed.2011.16.
7
Coprogression of Cardiovascular Risk Factors in Type 1 Diabetes During 30 Years of Follow-up in the DCCT/EDIC Study.在糖尿病控制与并发症试验/糖尿病干预与并发症流行病学研究(DCCT/EDIC研究)30年随访期间1型糖尿病患者心血管危险因素的共同进展
Diabetes Care. 2016 Sep;39(9):1621-30. doi: 10.2337/dc16-0502. Epub 2016 Jul 19.
8
The effect of excess weight gain with intensive diabetes mellitus treatment on cardiovascular disease risk factors and atherosclerosis in type 1 diabetes mellitus: results from the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study (DCCT/EDIC) study.强化糖尿病治疗中体重过度增加对 1 型糖尿病心血管疾病危险因素和动脉粥样硬化的影响:来自糖尿病控制和并发症试验/糖尿病干预和并发症流行病学研究(DCCT/EDIC)的结果。
Circulation. 2013 Jan 15;127(2):180-7. doi: 10.1161/CIRCULATIONAHA.111.077487. Epub 2012 Dec 4.
9
Association between 7 years of intensive treatment of type 1 diabetes and long-term mortality.1型糖尿病强化治疗7年与长期死亡率之间的关联。
JAMA. 2015 Jan 6;313(1):45-53. doi: 10.1001/jama.2014.16107.
10
Association of Insulin Dose, Cardiometabolic Risk Factors, and Cardiovascular Disease in Type 1 Diabetes During 30 Years of Follow-up in the DCCT/EDIC Study.在 DCCT/EDIC 研究 30 年的随访中,1 型糖尿病患者的胰岛素剂量、心血管代谢危险因素与心血管疾病的相关性。
Diabetes Care. 2019 Apr;42(4):657-664. doi: 10.2337/dc18-1574. Epub 2019 Feb 6.

引用本文的文献

1
The NIDDK Takes on the Complications of Type 1 Diabetes: The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study.美国国立糖尿病、消化和肾脏疾病研究所应对1型糖尿病并发症:糖尿病控制与并发症试验/糖尿病干预与并发症流行病学(DCCT/EDIC)研究。
Diabetes Care. 2025 Jul 1;48(7):1089-1100. doi: 10.2337/dc24-2885.
2
Long-Term Retention of Young Adult Study Participants with Youth-Onset Type 2 Diabetes: Results from the TODAY2 Study.青年起病 2 型糖尿病患者的长期随访:来自 TODAY2 研究的结果。
Horm Res Paediatr. 2023;96(3):325-331. doi: 10.1159/000528205. Epub 2022 Nov 21.
3
The Treatment In Morning versus Evening (TIME) study: analysis of recruitment, follow-up and retention rates post-recruitment.早晨与晚上治疗(TIME)研究:招募、随访及招募后保留率分析
Trials. 2017 Nov 23;18(1):557. doi: 10.1186/s13063-017-2318-4.
4
Benefits and barriers to participating in longitudinal research of youth-onset type 2 diabetes: Results from the TODAY retention survey.参与青少年2型糖尿病纵向研究的益处与障碍:今日留存率调查结果
Clin Trials. 2016 Apr;13(2):240-3. doi: 10.1177/1740774515613949. Epub 2015 Nov 3.
5
Quality Control Measures over 30 Years in a Multicenter Clinical Study: Results from the Diabetes Control and Complications Trial / Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study.一项多中心临床研究30年的质量控制措施:糖尿病控制与并发症试验/糖尿病干预与并发症流行病学(DCCT/EDIC)研究的结果
PLoS One. 2015 Nov 3;10(11):e0141286. doi: 10.1371/journal.pone.0141286. eCollection 2015.
6
The diabetes control and complications trial/epidemiology of diabetes interventions and complications study at 30 years: summary and future directions.糖尿病控制与并发症试验/糖尿病干预与并发症的流行病学研究30年:总结与未来方向
Diabetes Care. 2014;37(1):44-9. doi: 10.2337/dc13-2148.
7
Celebrating 30 years of research accomplishments of the diabetes control and complications trial/epidemiology of diabetes interventions and complications study.庆祝糖尿病控制与并发症试验/糖尿病干预与并发症流行病学研究30年的研究成果。
Diabetes. 2013 Dec;62(12):3963-7. doi: 10.2337/db13-1108.
8
Effects of prior intensive versus conventional therapy and history of glycemia on cardiac function in type 1 diabetes in the DCCT/EDIC.DCCT/EDIC 研究中强化与常规治疗及血糖史对 1 型糖尿病患者心功能的影响。
Diabetes. 2013 Oct;62(10):3561-9. doi: 10.2337/db12-0546. Epub 2013 Mar 21.
9
Evolution of the study coordinator role: the 28-year experience in Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC).研究协调员角色的演变:在糖尿病控制和并发症试验/糖尿病干预和并发症的流行病学(DCCT/EDIC)中的 28 年经验。
Clin Trials. 2012 Aug;9(4):418-25. doi: 10.1177/1740774512449532. Epub 2012 Jun 22.

本文引用的文献

1
The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD study.2 型糖尿病患者症状性、严重低血糖与死亡的相关性:ACCORD 研究的回顾性流行病学分析。
BMJ. 2010 Jan 8;340:b4909. doi: 10.1136/bmj.b4909.
2
10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study.糖尿病预防计划结果研究中糖尿病发病率和体重减轻的10年随访
Lancet. 2009 Nov 14;374(9702):1677-86. doi: 10.1016/S0140-6736(09)61457-4. Epub 2009 Oct 29.
3
Effects of intensive glucose lowering in type 2 diabetes.强化降糖对2型糖尿病的影响。
N Engl J Med. 2008 Jun 12;358(24):2545-59. doi: 10.1056/NEJMoa0802743. Epub 2008 Jun 6.
4
Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial: design and methods.糖尿病心血管风险控制行动(ACCORD)试验:设计与方法
Am J Cardiol. 2007 Jun 18;99(12A):21i-33i. doi: 10.1016/j.amjcard.2007.03.003. Epub 2007 Apr 16.
5
Reasons for high retention in pediatric clinical trials: comparison of participant and staff responses in the Correction of Myopia Evaluation Trial.儿科临床试验中高保留率的原因:近视矫正评估试验中参与者与工作人员反应的比较
Clin Trials. 2005;2(5):443-52. doi: 10.1191/1740774505cn113oa.
6
Minimizing attrition in a long-term clinical trial of pediatric asthma.在一项小儿哮喘长期临床试验中尽量减少损耗。
Ann Allergy Asthma Immunol. 2003 Aug;91(2):168-76. doi: 10.1016/S1081-1206(10)62173-4.
7
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin.通过生活方式干预或二甲双胍降低2型糖尿病的发病率。
N Engl J Med. 2002 Feb 7;346(6):393-403. doi: 10.1056/NEJMoa012512.
8
Factors differentiating dropouts from completers in a longitudinal, multicenter clinical trial.在一项纵向多中心临床试验中区分退出者与完成者的因素。
Nurs Res. 2000 Mar-Apr;49(2):109-16. doi: 10.1097/00006199-200003000-00008.
9
Epidemiology of Diabetes Interventions and Complications (EDIC). Design, implementation, and preliminary results of a long-term follow-up of the Diabetes Control and Complications Trial cohort.糖尿病干预与并发症流行病学研究(EDIC)。糖尿病控制与并发症试验队列长期随访的设计、实施及初步结果。
Diabetes Care. 1999 Jan;22(1):99-111. doi: 10.2337/diacare.22.1.99.
10
Successful techniques for retention of study participants in an inner-city population.在内城区人群中留住研究参与者的成功技巧。
Control Clin Trials. 1998 Dec;19(6):544-54. doi: 10.1016/s0197-2456(98)00032-4.